Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 April 2022 | Story Bhekumusa N. Zikhali
Africa Week
2022 Africa Week: ‘African Higher Education – Celebrating African Education’



Celebrating Africa Month – call for contributions


The University of the Free State Office for International Affairs, in collaboration with the Unit for Institutional Change and Social Justice, will be hosting its fifth annual Africa Day commemoration. The 2022 commemoration will be hosted across all three campuses in a marathon we call Africa Week, which unifies the activities through cross-campus collaboration speaking in one voice for one institution. The activities will be three-tiered, starting with an opening ceremony for Africa Week on the South Campus, a celebratory dialogue on the Bloemfontein Campus, and lastly, the closing ceremony of Africa Week on the Qwaqwa Campus. All three activities will be embodied under the theme ‘African Higher Education – Celebrating African Education’, which will embrace artistic expressions, music, dance, and meaningful dialogue that will provide an element for teaching and learning. You are all cordially invited to tune in.

In accordance with COVID-19 protocols/rules, the different activities will have limited capacity for attendance, but live streaming will be made available to the rest of us. This may change at any given time according to circumstances as determined by the relevant departments of the institution.

You are all cordially invited to tune in; be on the lookout for the RSVP link for attendance. In the meantime, save the date and the links below.

Livestream link: https://livestream.ufs.ac.za/

Opening Ceremony South Campus
Date: 23 May 2022
Venue: Open space outside the cafeteria
Time: 13:00 – 15:00

Celebratory Dialogue Bloemfontein Campus
Date: 25 May 2022
Venue: Centenary Complex
Time: 16:00 – 19:00

Closing Ceremony Qwaqwa Campus
Date: 27 May 2022
Venue: VIP Hall
Time: 12:30 – 15:00





 

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept